Circulating MicroRNAs linked to type 2 diabetes

Circulating MicroRNAs linked to type 2 diabetes
Circulating microRNAs are associated with type 2 diabetes, and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care.

(HealthDay)—Circulating microRNAs (miRNAs) are associated with type 2 diabetes (T2D), and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care.

Francisco J. Ortega, Ph.D., from the Institut d'Investagació Biomédica de Girona in Spain, and colleagues assessed the circulating miRNA profile in 12 men: six with normal tolerance (NGT) and six with T2D. In an extended sample of 45 men with NGT and 48 with T2D, the association of 10 circulating miRNAs with T2D was validated cross-sectionally. Longitudinal validation was performed in 35 patients with T2D who were recruited in a randomized three-month metformin trial. In seven healthy volunteers, circulating miRNAs were also assessed before and after a six-hour hyperinsulinemic-euglycemic clamp and plus intralipid/heparin infusion.

In patients with T2D, the researchers identified increases in three miRNAs and decreases in seven miRNAs. After controlling for confounders, miR-140-5p and miR-423-5p independently accounted for 49.5 percent of fasting glucose variance. A discriminant function of four miRNAs (miR-140-5p, miR-423-5p, miR-195, and miR-126) was specific for T2D, with 89.2 percent accuracy. Significant changes in circulating miR-192, miR-140-5p, and miR-22 were seen with metformin but not placebo, in parallel to reduced fasting glucose and glycated hemoglobin. Decreased miR-222 was seen with insulin infusion during clamp, while increases in circulating miR-222 and miR-140-5p were seen with the intralipid/heparin mixture.

"This study depicts the close association between variations in circulating miRNAs and T2D and their potential relevance in ," the authors write.

The study was partially funded by an EFSD/Lilly Fellowship award.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Serum miR-21 putative biomarker for colorectal cancer

Jun 20, 2013

(HealthDay)—The oncogenic microRNA (miRNA) miR-21 is a potential biomarker for detection and prognosis of colorectal cancer (CRC), according to a study published in the June 19 issue of the Journal of the Na ...

Atherosclerosis: Specific microRNAs promote inflammation

Mar 22, 2013

(Medical Xpress)—Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. Researchers at Ludwig-Maximilians-Universitaet in Munich have now identified a microRNA that ...

Useful biomarkers for esophageal squamous cell carcinoma

Jan 25, 2011

A research team from China investigated the expression profile of miRNA in esophageal squamous cell carcinoma (ESCC). They found that miRNAs were deregulated and miR-143 and miR-145 were downregulated in ESCC.

Micro-RNA's contribute to risk for panic disorder

Mar 24, 2011

Studies in twin pairs suggest that 40% of the risk for panic disorder is heritable, yet the manner in which genes contribute to the risk for panic disorder is far from clear. To date, variations in a growing number of genes ...

Recommended for you

Pre-diabetes label 'unhelpful and unnecessary'

Jul 14, 2014

Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota.

User comments